Publications

5674 Results

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study

Authors
RP Whitehead;S McCoy;J Macdonald;SE Rivkin;MA Neubauer;SR Dakhil;HJ Lenz;MS Tanaka Jr;JL Abbruzzese
Journal / Conference
Investigational New Drugs 24:335-341
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S9923

Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma

Authors
G Von Burton;C Rankin;MM Zalupski;GM Mills;EC Borden;K Antman
Journal / Conference
American Journal of Clinical Oncology 29(1):59-61
Year
2006
Research Committee(s)
Sarcoma
Study Number(s)
S9802

Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer. A Southwest Oncolgy Group (SWOG) Trial.

Authors
SK Williamson;S McCoy;DR Gandara;SR Dakhil;KJ Yost;JC Paradelo;JN Atkins;CD Blanke;JL Abbruzzese
Journal / Conference
American Journal of Clinical Oncology 29(2):116-122, 2006.
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S0101

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16

Authors
D Petrylak;D Pauler Ankerst;CS Jiang;CM Tangen;MHA Hussain;PN Lara;JA Jones;ME Taplin;PA Burch;M Kohli;MC Benson;EJ Small;D Raghavan;ED Crawford
Journal / Conference
Journal of the National Cancer Institute 98(8):516-521
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials

Authors
JM Unger;CA Coltman Jr;JJ Crowley;L Hutchins;S Martino;R Livingston;J Macdonald;C Blanke;D Gandara;ED Crawford;KS Albain
Journal / Conference
Journal of Clinical Oncology 24(1):141-144
Year
2006

The prostate cancer prevention trial: design, biases, and interpretation of study results

Authors
PJ Goodman;IM Thompson Jr;CM Tangen;JJ Crowley;LG Ford;CA Coltman Jr
Journal / Conference
Journal of Urology 175:2234-2242
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)

Authors
PJ Hesketh;K Chansky;DHM Lau;JH Doroshow;CM Moinpour;RA Chapman;JW Goodwin;HM Gross;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(6):537-544
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0027

Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group study 9024

Authors
GP Swanson;J Faulkner;SR Smalley;MJ Noble;RL Stephens;TJ O'Rourke;GR Weiss;DP Quick;IM Thompson, Jr;ED Crawford
Journal / Conference
Journal of Urology 176:548-553
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9024

Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group study S0126

Authors
HL West;WA Franklin;J McCoy;P Gumerlock;R Vance;DHM Lau;K Chansky;JJ Crowley;DR Gandara
Journal / Conference
Journal of Clinical Oncology 24(12):1807-1813
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0126

Concurrent chemotherapy plus cetuximab or chemotherapy followed by cetuximab in advanced non-small cell lung cancer (NSCLC): a randomized phase II selectional trial SWOG 0342

Authors
K Kelly;RS Herbst;JJ Crowley;J McCoy;JN Atkins;PN Lara;SR Dakhil;KS Albain;ES Kim;DR Gandara
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7015
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0342